177 related articles for article (PubMed ID: 11594245)
1. Epidemiology of cardiovascular disease in type 2 diabetes.
Serrano Rios M
Int J Clin Pract Suppl; 2001 Sep; (121):4-7. PubMed ID: 11594245
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology of cardio-vascular complications of diabetes].
Grimaldi A; Heurtier A
Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidaemia and coagulation defects of insulin resistance.
Frohlich J; Steiner G
Int J Clin Pract Suppl; 2000 Oct; (113):14-22. PubMed ID: 11965826
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and dyslipidaemia.
Schwartz SL
Diabetes Obes Metab; 2006 Jul; 8(4):355-64. PubMed ID: 16776742
[TBL] [Abstract][Full Text] [Related]
5. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
Larrañaga I; Arteagoitia JM; Rodriguez JL; Gonzalez F; Esnaola S; Piniés JA;
Diabet Med; 2005 Aug; 22(8):1047-53. PubMed ID: 16026371
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance--a common link between type 2 diabetes and cardiovascular disease.
Lebovitz HE
Diabetes Obes Metab; 2006 May; 8(3):237-49. PubMed ID: 16634983
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
8. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
9. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
10. Prevention of coronary heart disease in type 2 diabetes.
Mykkänen L
Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
[TBL] [Abstract][Full Text] [Related]
11. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
Steinmetz A
Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
[TBL] [Abstract][Full Text] [Related]
12. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
Reasner CA
J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
[TBL] [Abstract][Full Text] [Related]
13. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
Temelkova-Kurktschiev T; Hanefeld M
Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
[TBL] [Abstract][Full Text] [Related]
14. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
15. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
Rader DJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.
McLaughlin T; Abbasi F; Lamendola C; Reaven G
Arch Intern Med; 2007 Apr; 167(7):642-8. PubMed ID: 17420421
[TBL] [Abstract][Full Text] [Related]
17. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
Shepherd J
Atheroscler Suppl; 2005 Sep; 6(3):15-9. PubMed ID: 16046280
[TBL] [Abstract][Full Text] [Related]
18. Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.
Bruckert E; Baccara-Dinet M; Eschwege E
Diabet Med; 2007 Apr; 24(4):388-91. PubMed ID: 17335463
[TBL] [Abstract][Full Text] [Related]
19. Stroke prevention in diabetes and obesity.
Kurukulasuriya LR; Govindarajan G; Sowers J
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):487-502. PubMed ID: 16918267
[TBL] [Abstract][Full Text] [Related]
20. Diabetes and cardiovascular risk markers.
Erdmann E
Curr Med Res Opin; 2005; 21 Suppl 1():S21-8. PubMed ID: 15811196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
